HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Plasma Cell Neoplasm

Plasma Cell Neoplasm

Plasma cell neoplasms are a group of disorders characterized by the abnormal proliferation of plasma cells, a type of white blood cell that produces antibodies. The most well-known plasma cell neoplasm is multiple myeloma, a cancer of plasma cells that infiltrates the bone marrow. Despite significant advancements in treatment, including novel immunotherapies and targeted therapies, multiple myeloma remains incurable and can be challenging to manage due to its heterogeneity and potential for relapse. Research in this field focuses on understanding the underlying genetic and molecular mechanisms driving plasma cell neoplasms, identifying novel therapeutic targets, and developing personalized treatment strategies to improve patient outcomes. Emerging therapies such as chimeric antigen receptor (CAR) T-cell therapy offer promising avenues for more effective and durable responses in patients with relapsed or refractory disease.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp